Why the cost of Mounjaro is increasing — and what it means for you

Where the price rise came from

Eli Lilly set the UK list price for Mounjaro pens in 2023 and held it steady through to mid-2025. Then, from 1 September 2025, those list prices were revised substantially upward, with the 15mg pen's list figure more than doubling, from around £122 to around £330. This was widely reported in August 2025, and private providers had little choice but to reflect it. It is worth reading Eli Lilly's own UK communications if you want the manufacturer's position directly.

The background context matters here. Mounjaro (tirzepatide) is the only dual GIP and GLP-1 receptor agonist licensed in the UK for weight management, and the evidence base behind it is substantial: the SURMOUNT-1 trial recorded average body-weight reductions of around 20–21% at the 15mg dose over 72 weeks, published in the New England Journal of Medicine. NICE issued its formal recommendation in December 2024 (TA1026), which further cemented demand. Higher demand and revised manufacturer pricing together explain what you are seeing on invoices right now. The full breakdown of how much the price increased by dose gives a clearer picture of what each pen-strength costs relative to where it started.

One practical note: if your next order lands around a bank holiday or payday weekend, same-day dispatch depends on orders placed before 12pm on a working day, worth building into your timing so there is no gap in supply.

What headline prices often leave out

The figure advertised by many providers is the medicine cost alone. That can be misleading, because several things often sit outside that number: a consultation fee charged separately, a prescription fee added at checkout, a delivery charge, and (less visibly) the cost of any ongoing support if you need a dose review or hit a side effect.

When the list price was lower, a modest consultation fee felt like a small addition. Now that the medicine itself costs more, those add-ons become more noticeable as a share of a total monthly spend. The full breakdown of current Mounjaro pricing covers what different providers include and what they charge separately. Understanding that breakdown is the right starting point before you compare two services on headline figures alone. For a closer look at how the 5mg dose specifically has moved, the 5mg price increase detail is a useful reference, because the mid-range doses are often where people spend the most months of their treatment.

At nume, one price covers consultation, prescription, the treatment itself, next-working-day delivery and aftercare. Nothing extra appears at checkout. We are not the cheapest provider (that is a deliberate choice, not an oversight) but the figure you see is the figure you pay.

Why 'cheapest' is the wrong question for a prescription medicine

A lower price for a Prescription-Only Medicine should prompt a question, not a click. The MHRA has warned publicly about counterfeit weight-loss pens circulating through online and social-media channels, fake pens have contained insulin rather than tirzepatide, and enforcement action in 2025 included a raid on an illicit UK manufacturing site producing counterfeit tirzepatide pens, with around 20 million doses of illegally traded weight-loss medicines seized across that year. You can report a suspect seller via the MHRA's Yellow Card scheme. You can also verify any online pharmacy against the GPhC register before handing over payment details, nume's registration number is 9012878.

Beyond counterfeits, a service charging significantly below market rate often cuts corners on clinical oversight. Every legitimate supply requires a prescriber to assess your health history, current medications and BMI; that process cannot ethically be skipped, and its cost is real. Sellers offering these medicines without a prescription are operating illegally and putting patients at risk. The cost increase context page explains this in more depth, including what legitimate clinical oversight should look like.

For tirzepatide specifically, NICE's appraisal (TA1026) and the NICE recommendation both sit within a framework that assumes supervised, clinically reviewed prescribing. That framework is there for good reason. Price is a fair thing to scrutinise; it should just be scrutinised in full, not just at the headline.

Getting assessed without paying extra layers of fees

If the price increase has you reassessing which provider you use, the right comparison is total cost against total service. A clear look at what tirzepatide actually costs through different routes (NHS, private clinic, online pharmacy) helps you see the full picture. The NHS route is free at point of use but criteria are strict and phased; current cohorts require a BMI of 40 or above alongside multiple qualifying conditions, with wider access phasing in gradually. For people who do not meet NHS criteria or prefer not to wait, a private regulated pharmacy is the realistic route.

Our prescribers review every consultation personally on the day it arrives. If you are transferring from another provider or moving up a dose, the clinical re-review happens before anything is dispatched. You can read more about how that works on our about page, or get in touch if you have a specific question before you start. When you are ready, the free consultation is the place to begin.